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Two substances  related  to  adenine  and  both  bearing raSH  groups  have 
recently moved into prominence because of their biological effects: coenzyme 
A, as the coenzyme of biological acetylations or 2-carbon transfers  (1), and 
6-mercaptopurine (2),  as an antagonist  of physiological purines and  nucleic 
acids and as a potential anti-cancer agent (3, 4). 
Coenzyme A has been found to be highly beneficial to tissue cultures and to 
prolong their survival in incomplete media  (5). 
The agent  6-mercaptopurine is  reported  to  decrease mitotic incidence  in 
tissue cultures (6). In cultures of Crocker mouse sarcoma 180 exposed for 24 
hours to !  m~ 6-mercaptopurine, mitotic incidence is about 15 per cent of that 
in untreated cultures. Embryonic mouse skin cultures are less affected. In them, 
similax treatment reduces mitotic incidence to about 50 to 70 per cent of the 
incidence in control cultures. The partial mitotic inhibition in embryonic skin 
cultures caused by 6-mercaptopurine is readily blocked by simultaneous ad- 
ministration of any one of a number of physiological purines, nucleosides, and 
nucleotides. However, these substances are not so effective in protecting sar- 
coma  180  cultures against  6-mercaptopurine.  On  the  other hand,  the more 
complex material,  coenzyme  A,  readily  blocks  6-mercaptopurine-induced 
mitotic inhibition,  and  it  is  more effective in  this  respect for sarcoma  180 
cultures than for embryonic skin cultures. Thus in its effect the coenzyme is 
complementary  to  that  of  the  simpler  adenine-containing  metabolites.  As 
little as 0.02 m~ coenzyme A can block the mitotic inhibition of sarcoma  180 
cells caused by 1.0 mM 6-mercaptopurine (6). 
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The work reported earlier (6) was carded out with a commercial  preparation 
assaying 30  per  cent  coenzyme A.  The  present paper  reports  results  with 
commercial preparations assaying about 75 per cent coenzyme A. The antago- 
nism between 6-mercaptopurine and coenzyme A  with respect to mitotic inci- 
dence is confirmed. In addition, the two agents are found to have what may be 
interpreted as opposite effects  on mitochondrial morphology and on cellular 
lipogenesis. 
Methods  and Materials 
Tissue cultures of embryonic mouse skin and Crocker mouse sarcoma 180 were planted 
on coverslip inserts held to the flattened walls of roller tubes with a plasma clot. Two Cover- 
slips were in each tube. Each coverslip bore one explant of sarcoma 180 and two explants of 
embryonic skin under a thin clot of plasma. In each roller tube was 1.0 ml. of fluid nutrient 
medium consisting of 4 parts Gey's balanced salt solution, 2 parts 50 per cent chick embryo 
extract,  3 parts horse serum, and 1 part human cord serum. Penicillin G  (25 units) and 
streptomycin (25 #g.) were added in the salt solution. 
The cultures were incubated at 37°C. in a drum rotating at 6 revolutions per hour for 24 
hours. The cultures were then dosed with 6-mercaptopurine and coenzyme A in saline solu- 
tions, 0.1 mi. of the fluid medium in each tube being replaced with a like volume of saline 
containing the agent. Incubation then continued for another 24 hours. 
On the 3rd day, coverslip inserts were removed from the tubes for phase contrast photo- 
micrography. The plasma clot was carefully wiped from the back of the coverslip. The cover- 
slip was set, cultures down, in a drop of the fluid medium on a  microscope slide and ex- 
amined under oil immersion. Several photographs were rapidly made, and the next coverslip 
was then removed for examination. Mitochondrial lengths were measured in photographs of 
ten cells for each of the four experimental conditions: (a) control,  (b) treated  with 6-mer- 
captopurine,  (¢) treated  with coenzyme A in addition to 6-mercaptopurine, and (d) treated 
with coenzyme A alone. 
Other cultures were fixed with alcohol-acetic acid 3:1, stained with the Feulgen nucleal 
reaction  and light  green,  and  mounted  in diaphane  on microscope slides as  permanent 
mounts.  One thousand  nuclei in the outgrowth  of each culture  were counted in order to 
determine mitotic incidence under the several experimental conditions. 
Still Other coverslip cultures  were fixed in 10 per cent neutral formalin, stained  with 
Sudan black B in 70 per cent alcohol, and mounted in glycerogel for a demonstration  of 
lipid to supplement the phase contrast observations. 
The 6-mercaptopurine was kindly furnished by Dr.  G. H.  Hitchings of the Weltcome 
Research Laboratories,  Tuckahoe, New York.  The 75 per cent coenzyme A preparations 
were obtained commercially as fluffy white powders. 
RESULTS 
Mitotic counts in the outgrowths of stained cultures confirmed the partial 
mitotic inhibition  caused by 6-mercaptopurine and its blocking by coenzyme A. 
Results of an experiment with 75 per cent coenzyme A are presented in Table I. 
The mitotic inhibition caused  by 1  m,x  6-mercaptopurine is prevented  in 
sarcoma ceils by 0.2 or 0.02  mM  coenzyme A. Skin cells are protected by the 
higher but not the lower concentration of coenzyme A. These results are in 
complete accord with those obtained with a  30 per cent coenzyme A prepara- 
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Phase contrast photomicrographs of fibroblasts of the embryo mouse skin 
are presented in Figs. 1 to 5 in order to show effects of 6-mercaptopurine and 
coenzyme A on mitochondria. In Fig. 1 are fibroblasts of a control culture. The 
mitochondria are filamentous and of moderate length. After 24 hours' exposure 
to  1 mu 6-mercaptopurine (Figs. 2 and 3), the mitochondria of embryo skin 
fibroblasts are shorter. In some treated cells they appear thinner. Fig. 4 shows 
fibroblasts treated for a  day with a  combination  of  1  mx~ 6-mercaptopurine 
and  0.2  n~  coenzyme A.  The  mitochondria  resemble  those  in  untreated 
fibroblasts. In embryonic fibroblasts treated with  0.2  mM coenzyme A alone 
for 24 hours  (Fig.  5),  the mitochondria are  thicker and  longer than  in  the 
TABLE I 
E~ecls of 6-Mercaptopurin  e and Coen~yme A  on Mitotic Incidence in Tissue Cultures  from a 
S~g~ Exptrlm~t 
Concentration  Mitoses per I000 nuclei 
Sarcoma 180  Embryo skin 
6-Mercaptopurine 
mM 
1 
1 
1 
Coenzyme A 
fnM 
0.2 
0.02 
0.2 
Mean  Standard 
deviation 
M  o.p 
129.5  2.5 
17.5  3.5 
116.5  26.5 
93.5  10.5 
141.5  8.5 
Mean  Standard 
M  deviation 
O.t 
110.5  2.5 
55.0  2.0 
105.0  24.0 
62.0  10.5 
110.5  6.5 
control cells.  The mitochondria in Fig. 5 provide an extreme example of the 
coenzyme A effect. On the average, mitochondria are longer by about 50 per 
cent under coenzyme A treatment than under control conditions. 
A summary of the measurements of mitochondrial lengths in photographs is 
presented in Table II. Lengths of all mitochondria evident in each of ten cells 
under the four experimental conditions stated were measured and the arithmetic 
mean for each cell was determined. The mean of these individual cell means for 
each group of ten cells,  with its standard deviation calculated  as for a small 
sample, is entered in the table. Results such as these have been obtained in each 
of five separate experiments. 
The mean mitochondrial length is near 2/~ in control fibroblasts, approxi- 
mately half that value in cells treated with 6-mercaptopurine, near the control 
value in fibroblasts treated with coenzyme A in addition to 6-mercaptopurine, 
and about 3 ~t in cells treated with coenzyrne A alone. The difference in mean 
mitochondHal length between any two of these groups is statistically highly 
significant, with one exception: fibroblasts treated with 6-mercaptopurine plus 122  COENZYM'EA  AND MITOCHONDR~ 
coenzyme A have mitochondria not significantly different in length from those 
in untreated fibroblasts. 
Table  II also  contains  the average number of mitochondrla available  for 
measurement in the photographed optical sections of the ceils. These numbers 
by no means represent the total numbers of mitochondria per cell,  but  they 
must bear some relation to total numbers per cell. 
TABLE II 
A. Effects  of 6-Mercaptopurine and  Coenzyme A  on Mitockondrial  Lengths  and Number  of 
Mitockondria per Fibroblast in Optical Section 
Trestmeat  I No. ot cells 
(a) None 
(b)  6MP* 1 mK 
(¢)  6MP 1 mM plus CoA~L  0.2 mM 
(d)  CoA 0.2 my 
10 
I0 
10 
I0 
Mean mitochondrial 
length 
M~n  Staadard 
deviation 
0r  t 
j~ 
1.88 
0.96 
1.73 
2.94 
Mean mitochondrial 
No. 
~n 
0.07 
0.08 
0.11 
0.21 
38 
60 
53 
29 
Standard 
deviation  ¢, 
5.7 
5.5 
6.5 
3.7 
B. Stat~t~al Significance of DiJere~es be~en Mean Mit~t~Jrial I~gll~ 
T~t~neats compared  Probability that sampled  populations  are not diffc~eat 
(a) and (b) 
(a) and (c) 
(a) and (d) 
(b) and (c) 
(b) and (d) 
(c) and (d) 
P  <  0.0001 
P  ffi  0.25 
P  =. 0.0003 
P  < 0.0001 
P  <  0.0001 
P  ffi 0.0001 
* 6MP, 6-mercaptopurine. 
CoA, coeazyme A. 
The number of mitochondria observed per cell stands in a  roughly inverse 
relationship  to the mean mitochondrial length.  Treatment with  6-mercapto- 
purine increases the mean number of mitochondria visible per cell, and treat- 
ment with coenzyme A decreases the number visible per cell. Hence it may be 
suggested that mitochondria fragment under the influence of 6-mercaptopurine 
but coalesce end-to-end under the influence of coenzyme A alone. The change 
of importance may be one of mitochondrial surface area relative to volume. 
Observations  with  phase  contrast  microscopy  have  repeatedly  shown  a 
diminution in the quantity of refractile lipid droplets in cells treated with 6- 
mercaptopurine, and conversely, an increase over the control in cells treated 
with coenzyme A  alone.  In cells treated  with a  combination of 6-mercapto- J.  J.  BIESELE  123 
purine and coenzyme A, lipid droplets have usually been found intermediate 
in quantity between control  cells and those treated with 6-mercaptopurine 
alone. These changes are evident in Figs. 1 to 5, and they are also seen in cul- 
tures stained with Sudan black B (Figs. 6 to 9). 
DISCUSSION 
Mitochondria are  notoriously sensitive  to  unfavorable conditions of cell 
life, and the specificity of any morphological change in them is therefore open 
to question. However, an impressive  beginning in the interpretation of mor- 
phological changes in mitochondria has been made by the Belgian school Ch~- 
vremont  and  Chbvremont-Comhaire  (7)have  described  changes  in  tissue 
cultures treated with adrenochrome or its isomer, trihydroxy-N-methylindole, 
resembling  to  some  extent  the  effects of 6-mercaptopurine. Cells  treated 
with  trihydroxy-N-methylindole suffer preprophasic mitotic  inhibition and 
mitochondrial shortening, thickening, and rounding. Frederic (8) has described 
mitochondrial changes with a number of agents. Notable among these agents is 
2,4-dinitrophenol, well known for its apparent ability to dissociate oxidation 
from phosphorylation. Dinitrophenol increases mobility of the mit0chondria 
and causes them to become thicker and to lengthen by terminal fusion with 
one another. Their number per cell is thus decreased. These changes are sug- 
gestive of those caused by coenzyme A in our material. 
There is reason to look on the mitochondria as the principal sites of respira- 
tion in the cell (9) and on coenzyme A as being significantly involved therein. 
Enzymes of the Krebs cycle are relatively concentrated in the mitochrondrial 
fraction of normal liver homogenates (10), although several enzymes of the 
cycle occur in other fractions (11). The mitochondrial fraction contains about 
half the coenzyme A  and pantothenic acid of rat  liver homogenates (12). 
Coenzyme A is known to participate in the enzymatic condensation of acetate 
and oxalacetate to citrate (13,14) and thus to play a leading role in the introduc- 
tion of 2-carbon units into the tricarboxylic acid cycle. 
Coenzyme A is involved in a number of other enzyme systems localized in 
the mitochondria, including that catalyzing the formation of succinate from 
alpha-ketoglutarate in the citric acid cycle (15). It is instructive for our present 
purposes to note the mitochondrial localization of enzyme systems making use 
of coenzyme A in the metabolism of fatty acids (16-19). 
It is generally conceded that 6-mercaptopurine interferes with nucleic acid 
metabolism and that its toxicity in a  variety of biological  systems may be 
counteracted  by a number of physiological purines, nucleosides, and nucleotides 
(2,  20-24).  It has been reported that  6-mercaptopurine inhibits  "de  nolo" 
synthesis of nucleic acid and the incorporation of hypoxanthine but not of 
adenine into polynucleotides (25). There is suggestive evidence that isotopically 
labelled 6-mercaptopurine is itself incorporated into tissue  nucleic acids after 124  COENZYME  A  AND  MITOCHONDRIA 
injection into mice (26). However,  purine analogs are recognized to interfere 
in a variety of processes, and there is such a considerable variation in pharma- 
cological effect among a series of purine analogs studied as to render unsatis- 
factory all explanations of their mechanisms of action based soldy on antago- 
nism to the metabolism of purines or nucleic acids (27). 
Hence in considering the actions of 6-mercaptopurine  on tissue cultures, one 
may well be  wary of any unitary hypothesis of the mechanism of action. 
Blocking  of  the  6-mercaptopurine-induced  mitotic  inhibition  by  purines, 
nucleosides, and nucleotides, at least in embryo mouse skin cultures,  suggests 
that an interference  in nucleic acid metabolism is responsible for the mitotic 
inhibition. On  the  other hand,  the greater effectiveness  of coenzyme  A  in 
blocking  6-mercaptopurine-induced mitotic  inhibition casts  some  doubt on 
the primary importance of an upset in nucleic acid metabolism, unless coenzyme 
A is itself in some way involved in nucleic acid metabolism. 
Possibly of greater significance in the mitotic inhibition may be action by 
6-mercaptopurine  as an antimetabolite of coenzyme  A,  especially  an inter- 
ference in the introduction of 2-carbon units from glycolysis into the respiratory 
cycle. Energy production through the tricarboxylic  acid cycle is essential  for 
mitotic activity of the mouse ear epidermis in ~itro, according to work of Bul- 
lough and Johnson (28). One locus of attack by 6-mercaptopurine  might there- 
fore be in the mitochondria, in enzyme systems that provide energy or material 
needed for mitosis  or steps leading to mitosis.  Supporting evidence  on this 
point is the observation by Mihich that both oxygen consumption and carbon 
dioxide production by tumor slices from animals treated with 6-mercaptopurine 
are only about half of control values (29). The contrary effects of 6-mercapto- 
purine and coenzyme A on lipogenesis in vitro may perhaps also be considered 
as evidence of interference by 6-mercaptopurine  in a mitochondrial function of 
coenzyme A, participation in the biosynthesis  of fatty acids.  Whether inter- 
ference in lipogenesis by 6-mercaptopurine  bears more than a roughly parallel 
relation to mitotic inhibition is problematical. 
The alternative hypothesis may also be entertained that 6-mercaptopurine 
interferes in the synthesis of coenzyme A; Hamilton and Elion suggest  that 
6-mercaptopurine  may even  be  incorporated  into  the  structure of various 
coenzymes  (30). If this interference  does occur,  all processes  dependent on 
coenzyme A would be affected in cells treated with 6-mercaptopurine.  However, 
tissue culture experiments  now under way with the known precursors  of coen- 
zyme A  indicate  that  6-mercaptopurine  may not  interfere in  coenzyme  A 
biosynthesis. 
•  SUMMARY 
The partial mitotic inhibition caused by 6-mercaptopurine  in tissue cultures 
of Crocker mouse sarcoma  180 and embryonic mouse skin is blocked  by co- j.  j.  BIESELE  125 
enzyme A.  6-Mercaptopurine  and  coenzyme A  also have  opposite effects on 
mitochondrial  morphology.  Mitochondria  in  cells  treated  with  6-mercapto- 
purine become thin and fragmented.  Coenzyme A blocks this effect, and alone 
coenzyme  A  makes  for  longer  and  thicker  mitochondria,  6-Mercaptopurine 
inhibits  lipogenesis  in  embryo skin  fibroblasts,  and  this  inhibition  is partly 
counteracted by coenzyme A, which by itself makes for a greater accumulation 
of lipid droplets in the cytoplasm. 
It is suggested that  at least one part  of the action by which 6-mercapto- 
purine  decreases mitotic  incidence  in  tissue cultures may be an  interference 
on the part of 6-mercaptopurine,  acting as an antimetabolite  of coenzyme A, 
in mitochondrial  function related to cell division. 
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Photomicrographs  of  embryonic  mouse  skin  fibroblasts  2  days in  culture.  Oil 
~mmersion, dark medium phase contrast. ×  1090. 
Fie. 1. Ceils of control culture. Mitochondria appear as opgque rods or filaments 
of moderate le~,th. Cells also contain masses of lipid droplet~ 
FIo. 2. Cells of culture trested 1 day with 1 mM 6-metcaptopurine.  Mitochondria 
are short, sometimes beaded, rods and granules of intermediate  density. Cells con- 
tain little fat. 
FIG. 3. Different focal level of ceils in Fig. 2. THE  JOURNAL  OF 
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Photomicrographs  of  embryonic mouse  skin  fibroblasts  2  days  in  culture.  Oil 
immersion, dark medium phase contrast.  ×  1090. 
FIG. 4.  Cells of culture treated  1 day with  1 m~ 6-mercaptopurine and 0.2  m~ 
coenzyme A  together.  Mitochondria are opaque filaments of about same size as  in 
control cells of Fig. 1. These cells also contain many lipid droplets. 
FIG. 5. Cells of culture treated 1 day with 0.2  m~ coenzyme A alone. Mitochon- 
dria,  as  in distal cytoplasm, are long filaments. There are  several large masses  of 
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Photomicrographs  of  embryonic mouse  skin  cultures  fixed  with  formalin  and 
stained with Sudan black B. Epithelial cells and explant are to the right, fibroblasts 
are to the left. Standard light microscopy.  X  150. 
FIG. 6. Cells of a control culture. Sudanophilic lipid is seen as opaque cytoplasmic 
rings in epithelial cells and as masses  at either end of nucleus in fibroblasts. 
Fro.  7.  Cells  of  culture treated  1 day  with  1  m~  6-mercaptopurine.  The  ceils 
show little sudanophilia. 
FIG. 8. Cells of culture treated  1 day  with  1  mM  6-mercaptopurine and 0.1  mM 
coenzyme A  together.  Cellular sudanophilia is  intermediate between  that  of  con- 
trois and that of 6-mercaptopurine-treated cultures. Large opaque objects are masses 
of precipitated stain, not cells. 
FIG. 9. Cells of culture treated 1 day with 0.1  mM coenzyme A alone. Many cells 
are strongly sudanophilic. THE  JOURNAL  OF 
BIOPHYSICAL AND BIOCHEMICAL 
CYTOLOGY 
PLATE  39 
VOL.  1 
(Biesele: Coenzyme A and mitochondria) 